Antianginal and antiischemic effects of ivabradine, an If inhibitor, in stable angina: A randomized, double-blind, multicentered, placebo-controlled trial

Circulation

Volumn 107, Issue 6, 2003, Pages 817-823

  Borer, Jeffrey S ^a,e   Fox, Kim ^b   Jaillon, Patrice ^c   Lerebours, Guy ^d  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b ROYAL BROMPTON HOSPITAL   (United Kingdom)

^c SORBONNE UNIVERSITÉ   (France)

^d INSTITUT DE RECHERCHES INTERNATIONALES SERVIER   (France)

^e NONE   (United States)

Author keywords

Angina; Coronary disease; Ischemia

Indexed keywords

ANTIANGINA PECTORIS AGENT; IVABRADINE; PLACEBO; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BICYCLE ERGOMETER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG ACTIVITY; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; EXERCISE TOLERANCE; FEMALE; HEART MUSCLE ISCHEMIA; HEART MUSCLE OXYGEN CONSUMPTION; HEART MUSCLE PERFUSION; HEART RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OPEN STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REBOUND; SIDE EFFECT; SINUS NODE; ST SEGMENT DEPRESSION; STABLE ANGINA PECTORIS; STROBOSCOPY; VISUAL IMPAIRMENT;

ADULT; AGED; AGED, 80 AND OVER; ANGINA PECTORIS; BENZAZEPINES; DEPRESSION, CHEMICAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; ELECTROCARDIOGRAPHY; EXERCISE TEST; FEMALE; HEART RATE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; SINOATRIAL NODE; TREATMENT OUTCOME; VISION DISORDERS;

EID: 0037448788     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000048143.25023.87     Document Type: Article

References (31)

1. Management of stable angina pectoris. Recommendations of the Task Force of the European Society of Cardiology. Eur Heart J. 1997;18:394-413.
2. DiFrancesco D. Characterization of single pacemaker channels in cardiac sino-atrial node cells. Nature. 1986;324:470-473.
3. f) to generation of spontaneous activity in rabbit sino-atrial node myocytes. J Physiol. 1991;434:23-40.
4. Irisawa H, Brown HF, Giles W. Cardiac pacemaking in the sinoatrial node. Physiol Rev. 1993;73:197-227.
5. Bois P, Bescond J, Renaudon B, et al. Mode of action of bradycardic agent, S 16257, on ionic currents of rabbit sinoatrial node cells. Br J Pharmacol. 1996;118:1051-1057.
6. Thollon C, Cambarrat C, Vian J, et al. Electrophysiological effects of S 16257, a novel sino-atrial node modulator, on rabbit and guinea-pig cardiac preparations: comparison with UL-FS 49. Br J Pharmacol. 1994;112:37-42.
7. Gardiner SM, Kemp PA, March JE, et al. Acute and chronic cardiac and regional haemodynamic effects of the novel bradycardic agent, S16257, in conscious rats. Br J Pharmacol, 1995;115:579-586.
8. Simon L, Ghaleh B, Puybasset L, et al. Coronary and hemodynamic effects of S 16257, a new bradycardic agent, in resting and exercising conscious dogs. J Pharmacol Exp Ther. 1995;275:659-666.
9. Ragueneau I, Laveille C, Jochemsen R, et al. Pharmacokinetic-pharmacodynamic modeling of the effects of ivabradine, a direct sinus node inhibitor, on heart rate in healthy volunteers. Clin Pharmacol Ther. 1998;64:192-203.
10. Gibbons RJ, Chatterjee K, Daley J. et al. ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: executive summary and recommendations: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients with Chronic Stable Angina). Circulation. 1999;99:2829-2848.
11. Williams SV, Fihn SD, Gibbons RJ. Guidelines for the management of patients with chronic stable angina: diagnosis and risk stratification. Ann Intern Med. 2001;135:530-547.
12. Garratt KN. Stable angina pectoris. Curr Treat Options Cardiovasc Med. 2000;2:161-172.
13. Bucher HC, Hengstler P, Schindler D, et al. Percutaneous transluminal angioplasty versus medical treatment for non-acute coronary heart disease: meta-analysis of randomised controlled trials. BMJ. 2000;321:73-77.
14. Kjekshus JK. Importance of heart rate in determining beta-blocker efficacy in acute and long-term myocardial infarction intervention trials. Am J Cardiol. 1986;57:43F-49F.
15. Lechat P. Beta-blocker treatment in heart failure. Role of heart rate reduction. Basic Res Cardiol. 1998;93(suppl 1):148-155.
16. Berdeaux A, Drieu La Rochelle C, et al. Opposed responses of large and small coronary arteries to propranolol during exercise in dogs. Am J Physiol. 1991;261:H265-H270.
17. Bortone AS, Hess OM, Gaglione A, et al. Effect of propranolol on coronary vasomotion in response to sympathetic stimulation in humans: importance of the functional integrity of the endothelium. Circulation. 1990;81:1225-1235.
18. Lewis RV, Lofthouse C. Adverse reactions with beta-adrenoceptor blocking drugs: an update. Drug Saf. 1993;9:272-279.
19. Ramahi TM. Beta blocker therapy for chronic heart failure. Am Fam Physician. 2000;62:2267-2274.
20. Tattersfield AE. Respiratory function in the elderly and the effects of beta blockade. Cardiovasc Drugs Ther. 1991;4(suppl 6):1229-1232.
21. Krone W, Nagele H. Effects of antihypertensives on plasma lipids and lipoprotein metabolism. Am Heart J. 1988;116:1729-1734.
22. Lithell H, Pollare T, Vessby B. Metabolic effects of pindolol and propranolol in a double-blind crossover study in hypertensive patients. Blood Pressure. 1992;1:92-101.
23. Hakamaki T, Lehtonen A: Metabolic effects of spirapril and atenolol: results from a randomized, long-term study. Int J Clin Pharmacol Ther. 1997;35:227-230.
24. Reneland R, Alvarez E, Andersson PE, et al. Induction of insulin resistance by beta-blockade but not ACE-inhibition: long-term treatment with atenolol or trandolapril. J Hum Hypertens. 2000;14:175-180.
25. Pepine CJ, Abrams J, Marks RG, et al. Characteristics of a contemporary population with angina pectoris: TIDES Investigators. Am J Cardiol. 1994;74:226-231.
26. Bel A, Perrault LP, Faris B, et al. Inhibition of the pacemaker current: a bradycardic therapy for off-pump coronary operations. Ann Thorac Surg. 1998;66:148-152.
27. Kaneko A, Tachibana M. A voltage-clamp analysis of membrane currents in solitary bipolar cells dissociated from Carassius aureus. J Physiol. 1985;358:131-152.
28. Demontis GC, Longoni B, Barcaro U, et al. Properties and functional roles of hyperpolarization-gated currents in guinea-pig retinal rods. J Physiol. 1999;515:813-828.
29. (h)) in retinal rod photoreceptors. Neuropharmacology. 2000;39:1284-1291.
30. Frishman WH. Beta-adrenergic blocker withdrawal. Am J Cardiol. 1987;59:26F-32F.
31. Egstrup K. Transient myocardial ischemia after abrupt withdrawal of antianginal therapy in chronic stable angina. Am J Cardiol. 1988;61:1219-1222.